Transcriptome profiling of rattus norvegicus embryonic stem cells by RNA-sequencing by Johnson, Nathan Tyler
 
 
 
TRANSCRIPTOME PROFILING OF RATTUS 
NORVEGICUS EMBRYONIC STEM CELLS BY RNA-
SEQUENCING 
A Thesis  
presented to 
 the Faculty of the Graduate School  
of University of Missouri-Columbia 
In Partial Fulfillment  
of the Requirements for the Degree 
Master of Science 
By 
NATHAN TYLER JOHNSON  
 
Dr. Elizabeth C. Bryda, Thesis Advisor 
 
December 2014 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Nathan T. Johnson 2014  
All Rights Reserved 
  
 
The undersigned, appointed by the Dean of the Graduate School, have 
examined the thesis entitled  
 
 
TRANSCRIPTOME PROFILING OF RATTUS NORVEGICUS EMBRYONIC 
STEM CELLS BY RNA-SEQ 
 
presented by Nathan Tyler Johnson, 
a candidate for the degree of Master of Science 
and hereby certify that in their opinion it is worthy of acceptance. 
 
 
Dr. Elizabeth C. Bryda 
 
 
Dr. Kevin D. Wells 
 
 
Dr. James M. Amos-Landgraf 
 
 
  
 
DEDICATION 
I would like to dedicate this thesis to my wife, Amanda Johnson.  Without her 
love, patience, understanding, and simply putting up with my moods when things 
were not going right, made this work possible. Thank you for your continued 
support and journey. 
 
 ii 
 
ACKNOWLEDGEMENTS 
 
 There are many individuals that I would like to thank for their time and 
support while at the University of Missouri.  First, I would like to thank the 
members of my committee for their continued suggestions, comments, and 
support.  I would like to thank my extended lab mates Mary Shaw, and Anagha 
Sawant for being a sounding board for issues.  I would like specifically thank my 
lab manager Miriam Hankins for her continued support in all that I did.  I would 
like to thank my fellow graduate students simply for the pleasure of knowing 
them. I would like to thank my former committee members, Drs. Change Tan and 
Mark Kirk for their continued support. 
 Finally, last but definitely not the least, I would like to thank Dr. Bryda for 
her continued patience, guidance, and time.  Dr. Bryda challenged me to exceed 
expectations in all that I do, encouraged me when failing, and taught me how to 
critically analyze all that goes on around me.  I will forever be in Dr. Bryda’s debt 
for everything that she has taught me as I know that her influence will always be 
obvious in how I conduct myself as a scientist.   
  
 iii 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS .............................................................................................................. II 
LIST OF FIGURES ......................................................................................................................... IV 
LIST OF TABLES ............................................................................................................................ V 
ABSTRACT .................................................................................................................................... VI 
CHAPTER I ...................................................................................................................................... 1 
INTRODUCTION .......................................................................................................................... 1 
Purpose of the Research ......................................................................................................... 2 
Significance of the Research ................................................................................................... 2 
Organization of the Thesis ....................................................................................................... 2 
CHAPTER II ..................................................................................................................................... 4 
REVIEW OF THE LITERATURE .................................................................................................. 4 
Embryonic Stem Cells .............................................................................................................. 4 
Embryonic Stem Cell Isolation History ..................................................................................... 7 
RNA-Sequencing (RNA-Seq) ................................................................................................. 10 
RNA-Seq Analysis Pipeline .................................................................................................... 12 
Current State of ESC Transcriptomes ................................................................................... 20 
CHAPTER III .................................................................................................................................. 22 
MATERIALS AND METHODS ................................................................................................... 22 
Cell Line ................................................................................................................................. 22 
Mouse Embryonic Fibroblast (MEF) Cell Culture................................................................... 24 
RNA Extraction ....................................................................................................................... 24 
RNA-Seq ................................................................................................................................ 26 
Post-Sequence Analysis ........................................................................................................ 26 
Ortholog Processing ................................................................. Error! Bookmark not defined. 
Gene Ontology and Pathway Analysis ................................... Error! Bookmark not defined.9 
RT-PCR .................................................................................... Error! Bookmark not defined. 
Nucleotide Sequencing .......................................................................................................... 30 
CHAPTER IV ................................................................................................................................. 32 
RESULTS ................................................................................................................................. 322 
Gene Expression in rESCs .................................................................................................. 344 
Undescribed Isoforms .......................................................................................................... 377 
Undescribed Poly (A)
+
 Transcripts ......................................................................................... 41 
Rat, Human, and Mouse ESC Paired End RNA-seq Comparison....................................... 433 
CHAPTER V .................................................................................................................................. 49 
DISCUSSION ............................................................................................................................. 49 
APPENDIX A ................................................................................................................................. 56 
APPENDIX B ................................................................................................................................. 59 
APPENDIX C ................................................................................................................................. 60 
BIBLIOGRAPHY............................................................................................................................ 61 
 iv 
 
LIST OF FIGURES 
 
Figure 2.1……………………………………………………………..…..……………………..5 
Figure 2.2…………………………………………………………………...…………..………12 
Figure 2.3……………………………………………………………………...…………..……13 
Figure 2.4………………………………………………………………………...……………..18 
Figure 4.1………………………………...……………………………………………………..33 
Figure 4.2…………………………………………………………………………..…………...37 
Figure 4.3……………………………………………………………………..…..………….…41 
Figure 4.4…………………………………………………………..……………..…….………43 
Figure 4.5………………………………………………………..……………..………….……45 
Figure 4.6…………………………………………..…………………..……………….………46 
Figure 4.7………………………………………..…………………..…………………….……48 
 
 
 
 
 
 
 
 
 
 
 
 
 v 
 
LIST OF TABLES 
 
Table 4.1…………………………………………………………………………………...……34 
Table 4.2……………………………………………………………………………………..….34 
Table 4.3………………………………………………………………………………….……..38 
Table 4.4…………………………………………………………………………………..…….44 
Table 4.5………………………………………………………………………………..……….45 
 
 
 vi 
 
TRANSCRIPTOME PROFILING OF RATTUS NOREVEGICUS 
EMBRYONIC STEM CELLS BY RNA-SEQ 
Nathan T. Johnson 
Dr. Elizabeth C. Bryda, Thesis Advisor 
ABSTRACT 
 
Embryonic Stem Cells (ESCs) are a critical tool for producing targeted knockout 
animals and understanding development.  ESCs were successfully isolated from 
rats in 2008 and have been used in producing several targeted knockout animal 
models.  To date, little characterization of rat ESCs (rESCs) has been done.  In 
order to establish a rESC transcriptome, RNA-Seq was done on mRNA from the 
rESC cell line DAc8, the first male germline competent rat ESC line to be 
described and the first to be used to generate a knockout rat model.  RNA-Seq 
was chosen as it is currently the most sensitive transcriptome analysis method.  
In the studies described here, the genes expressed in rat ESCs were identified, 
and a subset of the undescribed isoforms and unannotated rat genes revealed by 
this analysis were confirmed by RT-PCR analysis.  Importantly, the rESC data 
allowed comparison with previously reported data for mouse and human ESCs to 
begin to understand the similarities and differences of the transcriptomes of 
ESCs from different mammalian species.  
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CHAPTER I 
 
 
INTRODUCTION 
 
Embryonic Stem Cells (ESCs) are a critical tool for producing targeted knockout 
animals and understanding development.  ESCs were successfully isolated from 
rats in 2008  and have been used in producing several targeted knockout animal 
models (Buehr et al. 2008; Li et al. 2008; Meek et al. 2010; Tong et al. 2010; 
Kawamata and Ochiya 2011; Tong et al. 2011; Yamamoto et al. 2011).  
However, despite their usefulness, detailed characterization of rat ESCs (rESCs) 
has been minimal and the transcriptome of rat ESCs has not been defined.  
Establishing the genetic expression pattern of normal rESCs will provide a base 
line for further exploring a variety of aspects of gene expression in rESCs for 
future experiments.  In order to establish a rESC transcriptome, RNA-
Sequencing (RNA-Seq) was performed with mRNA from the rESC cell line DAc8, 
the first male germline competent rat ESC line to be described and the first to be 
used to generate a knockout rat model. Undescribed isoforms and unannotated 
rat genes were identified and this data was confirmed by RT-PCR.  Additionally, 
the expression data for rat ESCs was compared and contrasted to previously 
reported data for human and mouse ESC expressed genes. 
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Purpose of the Research 
 
The objectives of this study are 1) to characterize the rESC transcriptome and 
determine what genes are expressed, and 2) to compare the rat ESC 
transcriptome with that of human and mouse ESC transcriptomes to gain insight 
into ESC expression patterns across species.  
Significance of the Research 
 
The rationale for this study is once we establish a normal expression pattern for 
rESCs, this expression pattern can be used as a baseline for gene expression in 
rESCs for comparisons with other rESC lines as well as human and mouse 
ESCs.  It allows commonalities among species to be explored. Importantly, it will 
allow comparisons with other rESCs to be possible in order to address 
fundamental questions such as what genes are important for maintaining 
pluripotency in rESCs or what genes are important for germline competency. 
Organization of the Thesis 
 
This thesis is divided into five chapters. Chapter I describes the purpose of this 
thesis. Chapter II is a review of the current relevant literature as related to the 
definition and use of embryonic stem cells, the differences among human, 
mouse, and rat embryonic stem cells, RNA-Seq as a tool for gene expression 
analysis, and the definition of the embryonic stem cell state.  Chapter III is a 
detailed description of the materials, methods, and experimental design. Chapter 
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IV contains the results. Chapter V is a discussion of the conclusions that can be 
drawn from the results of the research described in this thesis. 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
Embryonic Stem Cells 
 
The defining characteristics of Embryonic Stem Cells (ESCs) are 1) the ability to 
be maintained indefinitely in vitro in an undifferentiated state (Martin et al. 1977; 
Evans and Kaufman 1981; Martin 1981), 2) the ability to express pluripotency 
markers (Scholer et al. 1991; Ambrosetti et al. 1997), 3) the ability to contribute 
to all 3 germ layers (mesoderm, endoderm, and ectoderm) in vitro and in vivo 
(Kleinsmith and Pierce 1964; Brinster 1974; Martin and Evans 1975), and 4) the 
ability to contribute to the germline in vivo (Bradley et al. 1984; Schwartzberg et 
al. 1989; Smith 2001).   
ESCs are isolated from the inner cell mass of a blastocyst and can be maintained 
in the artificial laboratory environment for an extended period of time (Jakob 
1984).  A key aspect of ESCs is the capability to contribute to the germline in vivo 
(Suzuki et al. 1997).  Testing for this ability is analyzed by injecting ESCs into a 
blastocyst and following the genetic contribution of the ESCs in the resulting 
chimeric animal (Smith 2001).  Successful contribution is generally determined 
by coat color.  For example, ESCs carrying genes specifying for one coat color 
(i.e. black) will be injected into recipient blastocysts that carry genes specifying 
for another coat color (i.e. white). Therefore, if there is any contribution of the 
injected ESCs to the resulting animal, it will be evident in the coat color (i.e. black 
hairs on a primarily white coat, in this example, Figure 2.1).  These chimeras are 
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then bred in order to verify if their progeny will inherit genetic material contributed 
by the injected ESCs.  In the previous example, if the offspring of the chimera 
mated to a white coated animal have a black coat color it is evidence of germline 
transmission (Figure 2.1).  
 
Figure 2.1.  Rat Chimeras. The rat chimera (right) was generated by injection of Dark Agouti 
(DA) rat ES cells into a Fischer 344 (white) blastocyst and subsequent transfer of the embryo to a 
recipient Sprague-Dawley rat. The agouti coat color denotes the presence of DA ES cell–derived 
cells in the albino Fischer 344 host. The germline transmission of the DA ES cell genome in the 
offspring can be easily identified by the appearance of agouti coat color when the chimera is 
mated with albino Sprague-Dawley rats (Tong et al. 2011).  Image reproduced with permission 
from the Nature Publishing group. 
The study  of ESCs has had wide implications as both a basic research and 
therapeutic tool (Ben-David et al. 2012).  The increasingly growing interest in 
ESCs stems from their utility as tools for 1) genetic manipulation in order to 
produce animal models for studying human disease and/or gene function, and 2) 
asking general questions as related to genetics, epigenetics and/or cell biology, 
and stem cell therapy (Smith 2001; Bernstein et al. 2006; Fouse et al. 2008; 
Meissner et al. 2008; Guttman et al. 2009; Collin and Lako 2011; Huang et al. 
2011; Chan and Gantenbein-Ritter 2012; Ong and da Cruz 2012; Serra et al. 
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2012).  Generation of animal models for human disease and the creation of 
genetically modified animals to study the effects of knocking out genes has 
resulted in thousands of models that have revolutionized how scientists conduct 
research (Schofield et al. 2011).  This allows questions concerning a disease 
etiology to be answered without harming a human being in addition to facilitating 
therapeutic testing. 
ESCs have been used as a tool for identifying DNA demethylation enzymes, 
improving genomic techniques involving zinc finger nucleases and transcription 
activator like effector nucleases (TALENs), and long noncoding RNAs 
(lincRNAs), to name a few examples (Bhutani et al. 2010; Guttman et al. 2010; 
Hockemeyer et al. 2011; Tong et al. 2012).   Additionally, ESCs are used as 
therapies for curing disease and as controls for induced pluripotent stem cells 
(iPSCs) (Bilic and Izpisua Belmonte 2012; Chan and Gantenbein-Ritter 2012; 
Ong and da Cruz 2012; Serra et al. 2012).  iPSCs are thought to be the solution 
to morale issues concerning using ESCs since  iPSCs share the same 
pluripotent characteristics as ESCs, but are produced from differentiated cells 
rather than embryos (Sohn et al. 2012).  Additionally, since iPSCs can be 
isolated from the patient, the chance of immune rejection is less likely (Serra et 
al. 2012).  In order to produce iPSCs, differentiated cells have to be 
“reprogrammed” by a cocktail of transcription factors that reactivate pluripotent 
genes allowing for a more “naïve ” or embryonic stem cell-like state (Kang et al. 
2010).  In order for this naïve state to be understood, it is necessary to 
understand the embryonic stem cell state (Bilic and Izpisua Belmonte 2012).  
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Whether iPSCs or ESCs are a better stem cell solution to curing disease is still 
not clear (Bilic and Izpisua Belmonte 2012).  An understanding of ESCs is 
important to human health and to our understanding of basic biology. 
Embryonic Stem Cell Isolation History 
 
It is a matter of debate whether an ESC represents a transient cell state in vivo or 
is an artificial cell state made so due to the in vitro conditions imposed upon it 
(Smith 2001).  Additionally, over the last several decades defining what an 
“embryonic stem cell state” is has been met with some difficulty due to 
differences in isolation or the inability to isolate authentic ESCs in some species 
(Blomberg and Telugu 2012).  Difficulty in understanding the ESC state can be 
illustrated by the history of mouse, rat, and human ESCs (mESCs, rESCs, and 
hESCs respectively). 
The first ESCs were isolated from the 129 strain of mouse in 1981 (Evans and 
Kaufman 1981; Martin 1981).  The 129 strain proved consistently amenable to 
ESC derivation and genetic manipulation.  However, this strain has the 
disadvantage of poor breeding efficiency and is seldom the genetic background 
of choice (Brook and Gardner 1997).  Furthermore, multiple costly and time-
consuming generations of backcrossing are required to transfer a genetic 
alteration created using 129 ESCs to a different desired genetic background 
(Blair et al. 2011).  The original media used to isolate mESCs relied on undefined 
conditions, which included the use of fetal bovine serum (FBS) and growth of 
mESCs on a mitotically inactive mouse embryonic fibroblast feeder layer, which 
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were isolated at the same time-point of mESC isolation.  There have been 
several reports of wide variation in the quality of FBS, which can have diverse 
effects on mESC culture (Boone et al. 1971).  Due to this, defining the 
mechanism for mESC maintenance became a major goal.  In 1988, the key 
contribution of feeders was determined to be the IL-6 family cytokine LIF and in 
2003, the anti-neural cytokine BMP4 was found to substitute for serum (Smith et 
al. 1988; Williams et al. 1988; Ying et al. 2003).  Based on these findings, a 
feeder-free, serum-free culture condition for mESC derivation and maintenance 
was developed (Ying et al. 2003; Nagy and Vintersten 2006).  However, using 
these same conditions, researchers were unable to isolate rat or human ESCs 
(Daheron et al. 2004; Vallier et al. 2005). 
A decade later in 1998, human embryonic stem cells were successfully derived 
from human blastocysts, and maintained on a mouse feeder fibroblast layer with 
the addition of fibroblast growth factor (FGF) (Thomson et al. 1998; Levenstein et 
al. 2006).  Since it is considered unethical to test the ability of hESC to contribute 
to the germline, it is only possible to define human ESCs as such based on the 
expression of pluripotency genes and the ability to differentiate into all three germ 
layers.  Determination of this differentiation capability is based on transplanting 
hESCs into immune-deficient mice and demonstrating the formation of 
differentiated tumors compromised of all three germ layers (Hentze et al. 2009).  
Furthermore, there are mESCs and rESCs cell lines that meet the criteria of 
differentiation of all three germ layers in vivo, but not capable of contribution to 
the germline (Suzuki et al. 1997; Keefer et al. 2007).  However, it is not possible 
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to test whether hESCs contribute to the germline due to ethical concerns, 
because of this; the question is raised whether or not all hESCs are truly ESCs.   
For several decades it was possible to isolate “embryonic stem cell like” rat cells, 
which met all the criteria of an “embryonic stem cell state” except for the ability to 
go germline (Stranzinger 1996; Ruhnke et al. 2003; Demers et al. 2007; Ueda et 
al. 2008).  It was not until 2008, when a more basal understanding of the 
embryonic stem cell pluripotency network in mESCs allowed advances that 
enable the isolation of authentic germline competent rESCs (Sato et al. 2004; 
Chen et al. 2006; Buehr et al. 2008; Li et al. 2008; Li et al. 2009; Kanda et al. 
2012).  The key to this breakthrough appears to have been the development of 
an appropriate media. The new rat ESC media was originally termed 3 inhibitor 
(3i) media, but was later reformulated to include only 2 inhibitors (2i media) (Tong 
et al. 2011).  The philosophy behind the 2i media was ESCs do not need to be 
induced to be pluripotent, but rather they needed to be “shielded” from 
differentiation signals (Sato et al. 2004; Chen et al. 2006; Buehr et al. 2008; Li et 
al. 2008; Li et al. 2009; Kanda et al. 2012).    
While current knowledge of the ESC state has successfully allowed 
establishment of ESCs from rodents, primates, and fowl, attempts at isolating 
authentic ESCs from other species have been unsuccessful (Martins-Taylor and 
Xu 2010; Maruotti et al. 2012).  Identified impediments to success include 
differences in pluripotency characteristics, timing of pre-implantation embryo 
development, pluripotency pathways, and culture conditions (Mitchell et al. 2008; 
Cao et al. 2009; Alahdal 2011; Blomberg and Telugu 2012).  This leads to the 
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suggestion that there is more to the ESC state in different species than is 
currently understood. 
RNA-Sequencing (RNA-Seq) 
 
It is well established that one of the main components of phenotype is a direct 
result of genome wide differential gene expression and post transcriptional 
modification.  In order to understand gene expression, a genome wide approach 
must be taken.  Traditionally, this was and still is done with microarray 
technology in which a known set of fluorescently labeled oligonucleotide probes 
are immobilized to a solid substrate (Schena et al. 1995).  This array is then 
hybridized to RNA, allowing fluorescence to be measured based on the absence 
or presence of hybridization.  However, the major limitations to this approach are 
1) expressed gene sequences must be known in order to design probes, 2) only 
a limited number of genes can be analyzed at any one given time, and 3) lack of 
sensitivity because of the limitations of hybridization-based methodology (Malone 
and Oliver 2011).  Because of these limitations, it is estimated that microarray 
analysis can only detect medium to highly expressed genes, which account for 
only ~30% of the expressed transcripts or transcriptome (Evans et al. 2002).   
The recent advent of ultra-high-throughput next generation sequencing (NGS) 
technology such as RNA-Sequencing (RNA-Seq) provides a great deal more 
sensitive method for characterizing transcriptomes (Marioni et al. 2008; 
Mortazavi et al. 2008; Wang et al. 2009; Nowrousian 2010) (Figure 2.2). RNA-
Seq generates raw nucleotide sequence reads which are then efficiently mapped 
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to a corresponding reference genome, so that the overall cellular gene 
expression can be statistically determined (Mortazavi et al. 2008).  With the 
introduction of various NGS data analysis platforms, it has become much easier 
to identify splice variants, single nucleotide polymorphisms, undescribed genes 
and transcripts, and predict gene fusions at a much higher sensitivity as 
compared to hybridization-based techniques such as conventional microarrays 
(Mortazavi et al. 2008; Wang and Bucan 2008; Wall et al. 2009; Trapnell et al. 
2010; Edgren et al. 2011).   
RNA-Seq overcomes the limitations of microarrays since 1) expressed gene 
sequences do not need to be known, 2) unlimited numbers of genes can be 
analyzed at one time, 3) sensitivity is such that it is possible to detect a single 
copy of an expressed transcript (Chen et al. 2011; Jiang et al. 2011).  This 
technique enables efficient comparisons of expression levels among genes 
within a sample and among samples (McIntyre et al. 2011).  Additionally, this 
technique allows a greater number of analyses to be performed including 
detection of alternative splice forms, gene fusions, long noncoding RNAs, single 
nucleotide polymorphisms (SNPs), and new genes and transcripts (Mortazavi et 
al. 2008; Chepelev et al. 2009; Maher et al. 2009; Wall et al. 2009; Guttman et al. 
2010; Trapnell et al. 2010).  This has not only opened up the opportunity to 
analyze in-depth allele-specific gene expression and changes in RNA editing, but 
also provides the broad information to thoroughly evaluate and accurately predict 
molecular, cellular, and functional processes (Sanchez-Pla et al. 2012).  
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 RNA-Seq Analysis Pipeline 
 
The general strategy for RNA-Seq is shown in Figure 2.2.
 
Figure 2.2.  Steps in RNA-Seq pipeline used for establishing mRNA transcriptomes. Library 
preparation from total RNA involves poly (A)
+ mRNA selection, fragmentation, and random primer 
synthesis to make cDNA for each sample. The resulting library is sequenced and the output is 
analyzed by aligning the nucleotide sequence reads to a reference genome.  Figure modified 
from protocol for TruSeq RNA
TM
 sample preparation kit v2 (Illumina, San Diego, CA).  
The first step in RNA-Seq is to isolate messenger RNA (mRNA) from a tissue or 
cell type of interest.  This is typically done through poly (A)+  selection as all 
mRNA have poly (A)+ tails (Muller-McNicoll and Neugebauer 2013).  The RNA is 
converted to cDNA and the cDNA is sequenced to generate a series of short 
nucleotide sequences or “reads”.  The next step of analysis involves aligning 
sequences to a genome reference assembly and expression database to 
determine the identity of the transcripts present in the sample and calculate their 
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abundance (Torri et al. 2012).  Post-sequence analysis of RNA-Seq data is 
referred to as an RNA-Seq pipeline summarized in Figure 2.3. 
 
 
Figure 2.3. RNA-Seq Analysis Pipeline.  Initial steps of RNA-Seq involve quality control steps 
prior to data alignment to reference genome sequences available in a variety of public databases. 
Once the gene expression profile is determined, bioinformatics’ analysis is used to determine 
biological significance.  Results of RNA-Seq analysis can be independently confirmed using 
alternative strategies such as RT-PCR and microarray analysis. 
There are several layers of quality control necessary to ensure quality RNA-Seq 
data (Figure 2.3).  The 1st quality control step is ensuring that high quality RNA is 
used.  The definition of a “high” quality is based on the quantity of the 18S and 
28S ribosomal units with minimal degradation.  The quality of the RNA extracted 
directly relates to the quality of sequencing (Mortazavi et al. 2008).  The next 
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step is referred to a library preparation.  Prior to preparation of the library, the 
RNA must be fragmented by using a series of heat denaturation and cooling 
steps (Nagalakshmi et al. 2010).  Once fragmentation has occurred, cDNA is 
produced and oligos of defined sequence (adapters) are ligated to the cDNA.  
Adapter sequences are complementary to the sequence of oligos anchored to 
the chip used for sequence analysis.  During sequencing, each base is given a 
relative quality score highly dependent on the type of sequencer in order to 
depict sequence quality.  These quality scores are based on peak intensity, 
shape, and resolution (Dillies et al. 2012).  For example, Illumina uses Phred 
quality scores using the formula. 
Q = -10 log10 P 
Where P stands for error probability and Q stands for Q score.  A Q30 quality 
score is equivalent to the probability of an incorrect base call 1 in 1000 times or 
0.01%.  Using the Illumina Hi-seq 2000 next generation sequencer, in the case of 
the analysis reported here, the average size of the fragments was approximately 
200 bp.   
After sequence reads have been filtered for quality, determining where these 
reads align to a genomic sequence of an organism is necessary.  There are two 
main ways to assess where these reads align within a genome; de novo 
assembly and alignment to a reference genome (Dillies et al. 2012) (Figure 2.3).  
De novo assembly uses the reads in order to assemble a new reference 
sequence.  Issues with using RNA-Seq for de novo assembly are all current 
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algorithms such as commonly used Oases, Trinity, and trans-ABySSare are 
highly memory intensive and read preprocessing is absolutely necessary (Zhang 
et al. 2011; McGettigan 2013).  There is a potential for every technique to create 
artifacts.  In the case of RNA-Seq, these artifacts can be adapter contamination 
of sequence reads as well as low quality read scores.  Since de novo assembly 
algorithms assemble transcripts based on overlapping sequences, any 
homologous sequences allow for alignment.  Due to this, adapter contamination 
of sequence reads will produce false alignments.  Therefore, trimming reads due 
to quality and adapter contamination from library preparation is essential in order 
to provide assembly of authentic reads from the organism.  Alignment to a 
reference genome is a better solution than de novo assembly if the reference 
genome is an accurate build.    In this case, a previously assembled genome is 
used as a reference to align sequences.  This allows fewer misalignments due to 
sequencing artifacts (McGettigan 2013).   
Once reads have been mapped to a location in a genome, it is important to 
assign these reads to genes and determine the relative abundance of each gene.  
In order to make this possible, it is important to have a high quality annotated 
database such as Refseq, ENSEMBL, or UCSC Genome Browser (Flicek et al. 
2012; Pruitt et al. 2012; Meyer et al. 2013) (Figure 2.3).    Additionally, 
undescribed genes and isoforms can be determined due to the unique nature of 
RNA-Seq.  Since RNA-Seq is not a hybridization based analysis, anything being 
expressed can be detected (Garber et al. 2011).  This type of analysis is done by 
comparing aligned sequences with known gene annotation.  Any aligned 
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sequence not found in an annotation database is given the status of an 
undescribed gene if not “near” another gene.  If “near” another gene it is given 
the status of undescribed isoform.  The definition of “nearness” to another gene 
is dependent on the user’s conditions (Trapnell et al. 2010).   
Determining abundance of transcript expression is an essential task.  Transcript 
expression is typically reported as reads per kilobase per million (RPKM).  This 
metric allows for an “apples to apples” comparison among genes independent of 
gene length by normalizing the number of mapped reads with the transcript 
length and the total number of reads from an experiment (Mortazavi et al. 2008).  
RPKM takes into account the total number of mapped reads for a particular 
transcript, the length of the transcript, and the total number of reads in an 
experiment.  This is vital when trying to compare gene expression.  This allows 
for transcript expression to be compared among transcripts.  For example, if 
gene A is 100 bp long, and sequence reads are 50 bp, it is expected that if one 
transcript is expressed, two reads will be found.  Likewise, if gene B has a length 
of 10,000 bp, then 200 reads would be expected for every copy of the transcript 
expressed. (Mortazavi et al. 2008).   
After quantifying gene expression, it is then possible to assess biological 
functions for expressed genes.  There are a wide variety of methods to assess 
biological function to a given set of genes.  Generally speaking, databases 
utilizing Gene Ontology (GO) terms and association of genes with pathways and 
phenotypes are the hallmark across methods (Chen et al. 2011).  A GO term is a 
term or group of terms, such as glycolysis, embryo, or enzyme, which describe 
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the function of a gene.  By grouping genes based on thousands of terms, a 
network for function can be determined.  In an ongoing effort 
(www.geneontology.org), GO terms are assigned whether manually or 
automatically to a given gene based on information gleaned from orthologs, 
documented involvement in biochemical or signaling pathways, and/or known 
function (Ashburner et al. 2000).  Common databases using these terms are 
DAVID, KEGG, and Toppfun though the list is continually growing (Ogata et al. 
1999; Kanehisa and Goto 2000; Chen et al. 2009; Huang da et al. 2009; 
Kanehisa et al. 2012) (Figure 2.3). 
As with any method, analysis artifacts are possible when performing RNA-Seq 
therefore alternative strategies need to be used to validate the data.  Typically 
this is done either by a microarray or reverse transcription polymerase chain 
reaction (RT-PCR)  (Kogenaru et al. 2012) (Figure 2.3).   
However, despite the many advantages of RNA-Seq over other genome wide 
analysis, there are some limitations.  These limitations are short reads and a 
non-random distribution of reads.  Reads for RNA-Seq can range from 50 to 400 
bp depending on the instrument used (Marguerat and Bahler 2010). However, 
due to the demand for improvements for NGS technology, read lengths are 
expected to increase in the near future (Kircher and Kelso 2010).  But currently 
due to the shortness of RNA-Seq reads, inappropriate alignment of reads can 
occur.  For example, in cases where a pseudogene exists with significant 
homology to a functional gene, the programs used for analysis will not be able to 
determine whether the read should be assigned to the gene or the pseudogene.  
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(Balasubramanian et al. 2009).  This results in inadequate representation of a 
gene’s expression.  However, one way to get around the shortness of these 
small reads is to use paired end reads.  There are two types of reads for RNA-
Seq; single and paired end reads.  Single reads generate one single sequence 
read (Figure 2.4), whereas with paired end reads, a single read from each 
direction of a sequence is generated thus extending the length of the read 
(Garber et al. 2011).   
 
Figure 2.4.  Single End Reads vs Paired End Reads. Black lines represent adapters. Purple 
represents cDNA.  Blue arrows represent portion of a library prep sequenced. Blue lines refer to 
exons and red lines refer to introns of a gene.  Yellow lines refer to sequence reads.  Dashes 
among sequence reads indicate the sequences are paired.  Due to this, alignment is more 
accurate with paired end reads as more sequence is known. 
Previous studies have demonstrated that RNA-Seq reads do not follow a 
Guassian bell curve demonstrating a non-random distribution of reads or bias 
(Oshlack and Wakefield 2009; Li et al. 2010).  If there was a random distribution 
of reads, it would be expected there is an equal number of reads across an entire 
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transcript.  However, due to library preparation methods, transcript length, GC 
content, and nucleotide frequencies this is not the case (Linsen et al. 2009; 
Hansen et al. 2010; Li et al. 2010; Trapnell et al. 2010; Gao et al. 2011; Roberts 
et al. 2011).   
Attempts to normalize for RNA-Seq bias are possible during library preparation 
and analysis.  Library preparation involves mRNA pre-selection using beads that 
bind to the poly (A)+ tail.  RNA is then fragmented to generate small targets for 
the synthesis of cDNA.  This allows for 1) cDNA synthesis of difficult RNA targets 
that tend to form secondary structures, and 2) generation of multiple small cDNA 
molecules representing all the regions within long transcripts.  By improving 
fragmentation of RNA, a more random distribution of reads is possible (Roberts 
et al. 2011). 
Another strategy to decrease RNA-Seq bias is through the post-sequencing 
analysis.  One example is measurement of transcript expression based on 
assigning RPKM values (Mortazavi et al. 2008).  RPKM normalizes for transcript 
length and total number of reads in order to avoid inaccurate representation of 
data.   
However, it is reported that despite these attempts at normalizing, non-random 
distribution of reads still occurs.  This is evident by a 5’ bias of reads.  Higher 
quality and quantity of reads tend to be present at the 5’ end of reads.  This is 
hypothesized to be due to PCR in the RNA-Seq protocol.  In order to circumvent 
PCR bias, a technology needs to be developed that eliminates the PCR step. 
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(Hansen et al. 2010; Zheng et al. 2011; Wagner et al. 2012; Trapnell et al. 2013).   
Current State of ESC Transcriptomes 
 
Understanding of the exact regulatory mechanisms of the ESC state remains to 
be fully understood even though great advances have occurred (Chickarmane et 
al. 2012).  To this point, understanding the ESC state has predominantly been 
determined based on studies involving hESC and mESC.  Previous studies have 
only explored the rat ESC state by examining pluripotency markers across 
several strains (Buehr et al. 2008; Li et al. 2008; Hirabayashi et al. 2010a; 
Hirabayashi et al. 2010b; Tong et al. 2011).  hESC and mESC each have their 
own unique cell membrane markers (Calloni et al. 2013).  It has been assumed 
that rESCs are like mESCs because they share the same cell markers.  (Buehr 
et al. 2008; Li et al. 2008; Hirabayashi et al. 2010a; Hirabayashi et al. 2010b; 
Tong et al. 2011).  Whether or not rESC are truly similar to mESC and the 
degree of similarity or dissimilarity to hESC still remains to be determined. 
Current knowledge of the ESC state in both mESC and hESC relies on the core 
interaction of 3 transcription factors; Oct4, Sox2, and Nanog (Mitsui et al. 2003; 
Boyer et al. 2005; Niwa 2007).  Previous studies have shown that  knocking out 
or knocking down of  Oct4, Sox2, or Nanog results in an inability to maintain 
pluripotent cells (Nichols et al. 1998; Avilion et al. 2003; Buckler et al. 2009).  
However, Nanog can be removed once pluripotent cells have been established 
(Mitsui et al. 2003).  Additionally, these three transcription factors are found to 
 21 
 
co-localize to numerous genomic sites to activate or silence gene expression in 
order to maintain pluripotency (Richards et al. 2004; Assou et al. 2007; Zhou et 
al. 2007; Cloonan et al. 2008; Rosenkranz et al. 2008; Tang et al. 2010).  Based 
on this data, it is believed currently that maintenance of the ESC state is 
achieved by expression of these three transcription factors which 1) activate 
other pluripotency factors and repress lineage-specific genes, and 2) activate 
their own gene expression (Young 2011). 
In conclusion, there have been no comprehensive studies to characterize the rat 
ESC state or transcriptome, therefore the studies described here were 
undertaken.  The goals of this study were to 1) characterize gene expression in 
rESCs, and 2) to compare the rESC transcriptome to the human and mouse ESC 
transcriptomes to gain insight into ESC expression patterns across species.   
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CHAPTER III 
 
MATERIALS AND METHODS 
 
 
 
Cell Line 
 
The DAc8 (RRRC#464 DA-EC8/Rrrc cell line) was obtained through the Rat 
Resource and Research Center (http://www.rrrc.us) and was previously 
demonstrated to be an authentic rat embryonic stem cell line (Tong et al. 2010).  
Three vials of 1 x 106 cells at passage 27 were thawed from liquid nitrogen then 
pooled and plated onto two, 60 mm plates with 2i media on mitotically inactive 
mouse embryonic fibroblasts as described previously (Tong et al. 2011).  The 
following protocol is available at http://www.rrrc.us. 
Three vials of 1 x 106 cells at passage 27 were thawed from liquid nitrogen by 
agitating the vial in a 37 °C water bath.  Using a 5 mL serological pipette, 3 mLs 
of pre-warmed 2i media (Appendix A) was aseptically added to the rESCs and 
the resuspended cells were transferred into a 15 mL conical tube.  Another 2 
mLs of pre-warmed 2i media was used to rinse the vial and then added to the 
conical tube.  Rat ESCs were resuspended by slowly pipetting up and down until 
cloudy. The cells were pelleted by centrifugation at 150 g for 5 min and the 
supernatant removed and discarded.  The cells were resuspended in the 
appropriate volume (5 mL for 60 mm, 10 mL for 100 mm) of pre-warmed 2i media 
and pooled all three vials.  Cells were plated onto 2, 60 mm cell culture plates 
(Fisher, Asheville, NC, BD Falcon 353002) with previously plated mouse 
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embryonic fibroblast (MEF) (Millipore, Billerica, MA PMEF-N) (see following 
section for MEF preparation).  A hemocytometer was used to verify that 1.5 x 106 
million cells were plated for each plate to ensure starting with identical number of 
cells.  Plates were transferred to an incubator at 37 °C with 5% C02 and 90-100% 
humidity.   
The media was changed every 48 hrs or sooner if the media was yellow.  The 
media has a pH indicator, which turns yellow when acidic.  Rat ESCs can start 
differentiating within a couple of hours if the media turns yellow, so media must 
be changed immediately once it begins to yellow.  If rESCs colonies are at a high 
density (~70% confluency), then plating with 20 mLs (on 100 mm) of 2i media will 
circumvent this issue.  Rat ESCs colonies can be at a high density, but not high 
enough to passage at the ~48 hour time point.  Rat ESCs were passaged at 4 
days after thawing from cryopreservation and every 3 days afterward.  Rat ESCs 
were passaged by removal of all the 2i media and placing in a 50 mL conical 
tube.  Two mL of the removed 2i media was picked up by a 1000 uL pipette tip 
and gently washed over the plate.  When done correctly, rESCs will come off the 
MEF layer, but the MEFs will remain attached to the plate.  Rat ESC colonies we 
centrifuged at 150 for 5 min and the supernatant was removed and discarded.  
Colonies were resuspended in 5 mLs of pre-warmed TrypLE (Invitrogen, Grand 
Island, NY A1217701) and incubated at 37 °C for 5 minutes or longer.  Since 
rESC grow as colonies, they need to be disassociated from each other in order to 
create a one cell suspension.  TrypLE is used as it is a gentle means of 
disassociating these rESC colonies as it digests what binds the cells together.  
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The length of time for incubation is increased (in 3 minutes intervals) until the 
colonies are disassociated into a one to four cell suspension.  Rat ESCs grow in 
colonies, so one to four cells suspension is vital to ensure expansion due to one 
to four cells will give rise to 1 colony.  If the rESCs were not appropriately 
disassociated then expansion of rESCs would not be as robust.  
  Rat ESCs were plated at a 1:3 ratio and transferred to an incubator at 37 °C 
with 5% C02 and 90-100% humidity.  From thawing from liquid nitrogen to RNA 
extraction rESC expansion took a total of 16 days and resulted in 5, 100 mm 
plates per sample (15x106 cells) in order to have enough RNA for analysis.   
Mouse Embryonic Fibroblast (MEF) Cell Culture 
 
One day prior to bringing rESCs out of liquid nitrogen, MEFs (Millipore, Billerica, 
MA PMEF-N) are thawed and prepared by the same method as rESCs except 
MEF media (Appendix A) is used instead of 2i media.  The following changes are 
implemented for MEF culture.  1 vial (5-6x10^6 cells) of MEFs is sufficient for 3, 
100 mm or 8, 60 mm plates.  MEF cells were maintained by changing the media 
every 48 hrs.   
RNA Extraction 
 
At passage 30, rat ESC colonies were gently detached from the mouse 
embryonic fibroblast layer.  To reduce possible fibroblast and dead cell 
contamination, cells were allowed to sit on ice for 10 minutes which resulted in 
>90% of rat embryonic stem cell colonies settling to the bottom, while  fibroblasts 
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and dead cells tended to float  Cells were washed with 1xPBS (Invitrogen, Grand 
Island, NY 14190-136) by slowly pipetting PBS over cells and centrifuging for 5 
minutes at 800 g.  This was done twice.  RNA was extracted using Trizol 
(Invitrogen, Grand Island, NY 15596-026) followed by further purification using a 
Qiagen RNeasy kit (Valencia, CA 74106) according to manufacturers’ 
instructions.  Briefly, 2.25 mL of Trizol reagent was added per 0.75 mL of 
samples (~20-30x10^6 cells) then lysed by pipetting up and down several times.  
The homogenized sample was incubated at room temperature (RT) for 5 minutes 
after which 0.45 mL of chloroform was added.  The sample was shaken 
vigorously for 15 seconds, incubated at RT for 2-3 minutes, and centrifuged at 
12,000 g for 15 minutes at 4 °C.  The aqueous phase is pipetted into a new tube.  
RNA was precipitated by adding 1.2 mL of 100% isopropanol and incubated at 
RT for 10 minutes.  Samples were centrifuged for 10 minutes at 4°C.  The 
supernatant was removed and the pellet was washed with 2.25 mL of 75% 
ethanol.  Samples were gently shaken to break up the pellet and centrifuged at 
7500 g for 5 minutes at 4°C.  The pellet was air dried for 8 minutes then 
resuspended in 100 µL DEPC treated water by incubating at 55°C until 
resuspended (~10 min).  Additional purification was performed using Qiagen 
RNeasy (Valencia, CA 74104) kit using the RNA cleanup protocol.  Briefly, 350 
µL of Buffer RLT was added and the sample was mixed.  250 µL of ethanol was 
added then mixed by pipetting.  Samples were added to an RNeasy Mini spin 
column and centrifuged for 15 seconds at 8000 g.  The flow-through was 
discarded, and then 500 µL of Buffer RPE was added to the column and 
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centrifuged for 15 seconds at 8000 g.  The flow-through was discarded, 500 µL of 
Buffer RPE was added to the column and the samples were centrifuged for 15 
seconds at 8000 g.  The flow-through was discarded, and then the samples were 
centrifuge for 2 minutes at 8000 g.  50 µL of RNase free water was added to the 
column; the samples were incubated at RT for 1 minute then centrifuged at 8000 
g for 1 min.  This was done twice.  Samples were stored in 10 µL aliquots in 0.5 
mL tubes at -80°C until further use.   
RNA-Seq 
 
RNA integrity from extracted total RNA was determined using a RNA nano chip 
on an Agilent 2100 Bioanalyzer to determine a RNA integrity number (RIN).  
Samples 1 and 2 had a RIN of 9.8 and 9.6 respectively.  Approximately, 3.5 ng of 
total RNA was used for Illumina sequencing compatible library preparation using 
TruSeq RNATM sample preparation kit v2 (Illumina, San Diego, CA) according to 
the manufacturer’s protocol. Briefly, input RNA was purified by two rounds of poly 
(A)+ selection followed by chemical fragmentation. Random hexameric primers 
were used to generate cDNA from fragmented and primed RNA from the 
previous step using Superscript II reverse transcriptase. The cDNA was purified 
using Ampure XP beads and end repair was performed using a 3’-5’ exonuclease 
enzyme, which removed the 3’ overhang and filled the 5’ overhang thereby 
producing blunt ends on either sides of the ds cDNA. Indexed adapter ligation 
was performed by adenylating the 3’ end of this blunt cDNA to provide a 
complementary overhang to the corresponding ‘T’ nucleotide on the 3’ end of the 
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adapters. PCR amplification (15 cycles) was used to enrich the adapter ligated 
ds cDNA molecules to generate single read libraries.  
The final concentrations of the libraries were evaluated using a DNA 1000 chip 
on an Agilent 2100 Bioanalyzer.  5µl of each amplified library was diluted to 
15nM stock in 1% Tween, and 2µl of this stock was used for quantification using 
a KAPA SYBR® Fast Universal qPCR kit (Kapa Biosystems, Inc., Woburn, MA).  
Stock libraries were diluted to a final 10nm concentration for cluster generation 
on a cBot v1.4.36.0 using Illumina's Truseq PE Cluster Kit v3.0. Massive parallel 
paired-end (PE) sequencing was performed using a 200 cycle TruSeq SBS HS 
v3 kit on a HiSeq2000, running HiSeq Control Software (HCS) v1.4.8. The 
clustered flowcell was sequenced for 106 cycles, broken down into 3 separate 
reads.  The first read was 50 cycles in length, followed by a 6 cycle index read.  
Following the index read, paired end resynthesis was performed using Truseq 
PE Cluster Kit v3.0, which was then followed by another 50 cycles.   Image 
analysis and base calling were performed using the standard Illumina Pipeline 
consisting of Real time Analysis (RTA) version v1.12.4.2 and Casava v1.8 using 
the default settings. 
Post-Sequence Analysis 
Raw reads were aligned against the rat genome RGSC 5.0/rn5 using the default 
settings for TopHat (v1.4.0) resulting in > 95% of reads mapping to the rat 
genome assembly (Gibbs et al. 2004; Havlak et al. 2004).   
 28 
 
The bam files generated were uploaded onto a commercially available platform 
Avadis NGS (v 1.3) (Strand Scientific Intelligence, Inc.) for further downstream 
data analysis and alignment.  Gene alignment was conducted against RefSeq 
(10/21/2012) (http://www.ncbi.nlm.nih.gov/refseq/). Duplicate reads as well as reads 
with low mapping quality were removed.  The overall abundance of expressed 
genes was calculated as RPKM, Reads Per Kilobase of exon model per Million 
mapped reads as described earlier by Mortazavi et. al., 2008.  Additionally, 
adapter contamination was evaluated and considered not to be a significant 
variable.  The significance of adapter contamination was evaluated by using a 
script that takes the adapter sequence and determines the percentage of the 
reads that contain a portion of the adapter sequence.  None of the samples had a 
greater then random distribution of the adapter sequence.  Furthermore, when 
taking the adapter sequence and using BLAST against the rat genome there 
were >100 hits that matched 100% to genes. 
Ortholog Processing 
Output files from Avadis analysis were analyzed with g-profiler to determine the 
orthologs for each species (Reimand et al. 2011).   Gene symbols and 
ENSEMBL id were taken into account when determining orthologs as using both 
gives a more concise ortholog list.   A gene needed at least one ortholog in 
another species in order to be considered for downstream analysis.  Typically, 
genes that did not have orthologs were uncharacterized proteins. 
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Gene Ontology and Pathway Analysis 
Toppfun was used to analyze all Gene Ontology (GO) terms and perform 
pathway analysis in order to identify the most relevant biological term associated 
with a given gene list.  Toppfun is a program for gene list enrichment analysis 
based on functional annotation and protein interactions network (Chen et al. 
2009).  For pathway cluster analysis, Toppcluster and Cytoscape were used to 
generate cluster maps (Kaimal et al. 2010; Praneenararat et al. 2012). All 
statistical analysis was conducted using Bonferonni correction value at cut off of 
<0.05 p-value.  Due to the quantity of genes used in this analysis, it is typically 
considered good statistical practice to use a correction to reduce false positives.  
By using the Bonferonni correction value, the cutoff of the p-value is essentially 
changed to the threshold p-value of 0.000005. 
RT-PCR 
Total RNA was extracted from DAc8 samples as described previously.  cDNA 
synthesis was performed using Invitrogen Superscript III First-Strand cDNA 
synthesis following the manufacturer’s protocol.  Briefly, 2 µg of RNA per 20 µL 
reaction was set up on ice with 2 µM random primers, 200 U of SuperScript III 
reverse transcriptase, and 40 U of RNase inhibitor using the following thermal 
conditions: 25 C° for 10 min, 50 C° for 50 min, and 85 C° for 5 min.  1 µL of 
cDNA reaction was used for each PCR reaction with a specified primer set 
(Appendix C) and Faststart Taq (Roche, Indianapolis, IN) following the 
manufacturer’s protocol. Thermocycler conditions were 1 cycle of 95 C° for 3 
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min; 35 cycles of 94 C° for 30 seconds, 57 C° for 30 seconds, and 72 C° for 
either 30 seconds (Nras and Dnmt3b) or 1 min (Lef1).  Amplicons were analyzed 
on 3% (Nras and Dnmt3b) or 1% (Lef1) 1X TBE agarose gels by electrophoresis.  
Amplicons were gel purified using Qiagen’s gel extraction kit following the 
manufacturer’s protocol.  Amplicons were submitted to the University of Missouri, 
DNA Core for fragment analysis. 
Nucleotide Sequencing 
RT-PCR products were gel purified using Qiagen QIAuick Gel Extraction kit 
(Valencia, CA, 28704) using the manufacturer’s protocol.  Briefly, DNA fragments 
were excised with from the agarose gel using a scalpel.  Three volumes of Buffer 
QG to 1 volume of gel were incubated at 50 C° until dissolved.  Dissolved 
samples were applied to a QIAquick column and centrifuged at 15,000 g for 1 
min.  Flow-through was discarded and the samples were washed again with 0.5 
mL of Buffer QG and 0.75 mL of Buffer PE followed by an additional spin for 1 
min to remove residual ethanol.  DNA was eluted by incubating 30 µL of Buffer 
EB for 1 min on the column at RT then centrifuging at 15,000 g for 1 min.  Quality 
was assessed using a Nanodrop 8000 (Thermo Scientific, Wilmington, DE,  for a 
260/280 value of 1.80-2.00.  1500 ng of DNA was used for sequencing on a 
3730xl 96-capillary DNA Analyzer with Applied Biosystems Big Dye Terminator 
cycle.  All nucleotide sequence analysis was performed at the DNA Core 
(University of Missouri). 
Data Access 
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The data discussed in this publication have been deposited in NCBI's Gene 
Expression Omnibus (Edgar et al. 2002) and are accessible through GEO Series 
accession number GSE44150 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE44150) 
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CHAPTER IV 
 
 
RESULTS 
 
To perform the analysis, a rat embryonic stem cell line (DAc8) derived from the 
Dark Agouti (DA) inbred rat strain was chosen.  This male cell line is known to be 
germline competent and it has been used successfully for genetic manipulations, 
therefore, while characterization is minimal, it is one of only a few characterized 
rESC lines available and was a logical choice for generating the first rat ESC 
transcriptome. cDNA libraries from poly (A)+ mRNA from two biological replicates 
of the DAc8 cell line were deep sequenced at 50 base paired-end reads in order 
to generate a data set of expressed genes.  Sequencing generated a sum of 
more than 247 million reads for both samples.  Reads were filtered to remove low 
quality and duplicate reads (Table 4.1).  Adapter contamination was not filtered 
as it was determined not to be significant (see Materials and Methods).  The 
reads were aligned against rat genome RGSC 5.0/rn5 using TopHat (v1.4.0) with 
> 95% of reads mapping to the rat genome assembly (Gibbs et al. 2004; Havlak 
et al. 2004).  Expressed genes were calculated as reads per kilobase of exon 
model per million mapped reads (RPKM) as described previously by Mortazavi 
et. al, 2008.  RPKM values estimated from the 2 biological replicates used for the 
analysis were plotted on a scatter plot, which indicated that gene expression was 
highly consistent across both samples (Appendix B).  A total of 10,931 genes 
were detected based on a value of at least one RPKM per gene in both samples 
with a mean of 39.6 RPKM and a range from 1 to 2287 RPKM.  When comparing 
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both biological replicates, only 34 genes showed expression differences of 
greater than 1 fold log change among the samples.  4 of these 34 genes were 
chosen for verification (Figure 4.1).  The original analysis used the reference 
genome of rat genome RGSC 4.0/rn4.  This resulted in only 4 genes that showed 
a difference in expression.  Upon reanalysis using rn5 as a reference genome, 
the gene number was increased to 34.  Since, these 4 genes confirmed the 
predicted biological variance among the samples, it was determined not 
necessary to confirm the other 30 genes.   
 
Figure 4.1 Verification of biological variance among samples.  RNA-seq predicted 34 genes 
with a 1 log fold expression difference among sample 1 and 2.  To verify the difference, 
expression for 4 genes (LOC100359825, LOC1003645576, Q62676, and Q6LCG2) was 
determined among sample 1 and 2 using quantitative RT-PCR.  Fold change was determined 
based on ΔΔCt expression normalized to B2m.  Lines above bar graph represent the standard 
deviation for each gene.  Predicted biological variance among samples was confirmed for the 
genes tested. 
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Table 4.1 Number of filtered reads per species 
Species Genes 
Detected 
Average 
Number of 
Reads*  
Sequencer Reference 
rESC 10,931 94 million Illumina Hi Seq 2000 This study 
hESC 17,634 12 million  Illumina Genome 
Analyzer (GAI or GAIIx) 
(Birney et al. 
2007) 
mESC 14,417 67 million Illumina Genome 
Analyzer (GAI or GAIIx) 
(Guttman et al. 
2010) 
*There are 2 biological replicates each for mouse and rat and 4 for human. 
Gene Expression in rESCs 
 
A total of 10,931 genes were detected based on at least one RPKM per gene.  
The 25 most highly expressed genes in the DAc2 rat ESCs are genes that are 
known to be involved with the glycolysis pathway, glucose regulation of insulin 
secretion, and genes involved in energy metabolism (Table 4.2).   
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Table 4.2 Twenty-five most highly expressed rat embryonic stem cell genes. 
Gene 
Symbol 
Protein Name RPKM 
Aldoa Fructose-bisphosphate aldolase A 2286 
 
Eef2 Elongation factor 2 2035 
Gstp1 Glutathione S-transferase P 1478 
ATP5B ATP synthase subunit beta, mitochondrial 1424 
Gpi Glucose-6-phosphate isomerase 1343 
Pgk1 Phosphoglycerate kinase 1 1291 
Hsp90ab1 Heat shock protein HSP 90-beta 1268 
Pgam1 Phosphoglycerate mutase 1 1223 
Gnb2l1 Guanine nucleotide-binding protein subunit beta-2-like 
1 
1062 
Slc2a1 Solute carrier family 2, facilitated glucose transporter 
member  
1048 
Pabpc1 Polyadenylate-binding protein 1 1046 
Tubb5 Tubulin beta-5 chain 959 
Bsg Basigin 943 
Trim28 Transcription intermediary factor 1-beta 937 
Serbp1 Serpine1 mRNA binding protein 1 885 
Pdpn Podoplanin 861 
Scd Acyl-CoA desaturase 2 833 
Cct5 T-complex protein 1 subunit epsilon 785 
Akr1a1 Alcohol dehydrogenase [NADP+] 777 
Actb Actin, beta 719 
Fn1 Fibronectin Anastellin 717 
Ywhae 
 
Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, epsilon 
polypeptide 
658 
 
Igfbp2 Insulin-like growth factor-binding protein 2 655 
Utf1 Undifferentiated embryonic cell transcription factor 1 654 
Mlf2 myeloid leukemia factor 2 652 
Oaz1 ornithine decarboxylase antizyme 1 632 
 
These genes were analyzed further using ToppFun to determine statistically 
significant pathways, phenotypes, and Gene Ontology (GO) terms for biological, 
molecular, and cellular components (Chen et al. 2009).  A statistically significant 
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pathway, phenotype, and GO term are defined by the percentage of expressed 
genes out of the total number of genes associated with a certain function.   
The top 5 statistically significant GO terms for cellular components are mitotic cell 
cycle, cellular response to stress, intracellular transport, cell cycle process, and 
cell cycle  (Figure 4.2). The top 5 statistically significant GO terms for biological 
function are phosphotransferase activity, kinase activity, enzyme binding, 
transferase activity, and RNA binding (Figure 4.2). The top 5 statistically 
significant for molecular function GO terms are microtubule cytoskeleton, 
envelope, organelle envelope, ribonucleoprotein complex, and mitochondrial part 
(Figure 4.2).   
The top 5 statistically significant phenotypes include genes involved in embryonic 
lethality, embryogenesis/development, the embryogenesis phenotype, prenatal 
growth, and embryonic growth.  Due to phenotype similarity it should be noted 
that many genes are shared in common. 
The top 5 statistically significant pathways not including the cell cycle are genes 
involved in the diabetes pathway, influenza, HIV infection, signaling by neuronal 
growth factors, and insulin synthesis and secretion.  Pathways consist of groups 
of associated genes and pathway names often reflect the context in which the 
pathway was first identified and do not necessarily indicate global biological 
relevance.   
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Figure 4.2 GO terms for rat ESCs. The bar graphs on the left depict the top 5 GO terms that 
correspond to the highest statistical significant expression in rat ESCs for each category (cellular, 
biological, and molecular).  The Venn diagrams on the right include comparisons for each 
category of GO terms for all three species.    
Undescribed Isoforms 
 
Reads obtained by RNA-seq were aligned to known and predicted rat RNA 
sequences from RefSeq (/refseq/release/10/20/2012).  Reads that mapped to 
undescribed exon-exon junctions indicate the potential to be undescribed 
isoforms.  To verify the predicted undescribed isoforms have not been previously 
described ENSEMBL, UCSC, and NCBI were consulted.  After this analysis was 
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completed, 27 genes were predicted to have the potential for undescribed 
isoforms (Table 4.3).   
Table 4.3. Genes with predicted undescribed isoforms in rat ESCs.  
Gene Symbol Protein Name 
Ap3b1 AP-3 complex subunit beta-1 
Hmgcs1 Hydroxymethylglutaryl-CoA synthase, cytoplasmic 
Nras GTPase NRas 
Lef1 Lymphoid enhancer-binding factor 1 
Sptan1 Spectrin alpha chain, brain 
Prrc2b proline-rich coiled-coil 2B 
Rif1 Telomere-associated protein RIF1 
Dync1i2 Cytoplasmic dynein 1 intermediate chain 2 
Dnmt3b DNA (cytosine-5)-methyltransferase 3B 
Tpd52l2 Tumor protein D54 
Luc7l2 LUC7-like 2 
Dctn1 Dynactin subunit 1 
Clta Clathrin light chain A 
Mta1 Metastasis-associated protein MTA1 
Azin1 Antizyme inhibitor 1 
Ncaph2 Condensin-2 complex subunit H2 
Ubp1 upstream-binding protein 1 
Fn1 Fibronectin Anastellin 
Nmral1 NmrA-like family domain-containing protein 1 
Lig3 DNA ligase 3 
Cisd3 CDGSH iron sulfur domain-containing protein 3, mitochondrial 
Eif4h Eukaryotic translation initiation factor 4H 
Rsrc2 Arginine/serine-rich coiled-coil protein 2 
RGD1304704  Uncharacterized Protein 
RGD1304704 Uncharacterized Protein 
Ubqln1 Ubiquilin-1 
Dbn1 Drebrin 
 
To test the accuracy of the RNA-seq-based predictions of the undescribed 
isoforms, three genes (Nras, Dnmt3b, and Lef1) were chosen for further 
validation by RT-PCR and nucleotide sequence analysis (Figure 4.3).  These 
genes were chosen due to their biological significance for ESC biology.  
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Additionally, the homologues of these genes were compared to human and 
mouse.  For every gene, human and mouse had a higher number of isoforms 
known. 
The Nras gene is involved in the MEK/ERK signaling pathway and only one 
known rat isoform has been described (Gyorffy and Schafer 2010).  The RNA-
seq data predicted an undescribed isoform in which exon 6 was skipped.  
Primers were designed within exons 5 and 7 and based on RT-PCR and 
nucleotide sequence analysis, three amplicons were detected, including the full 
length isoform and the predicted isoform in which exon 6 was skipped. The third 
amplicon represented an artifact PCR product involving mispriming of the reverse 
primer to a duplicated sequence located in exon 11 of the Nras pseudogene 
(Figure 4.3). 
Dnmt3b is implicated in de-novo DNA methylation (Jin et al. 2013). The Dnmt3b 
gene has 24 exons and 3 isoforms have been identified in the rat.  Our RNA-seq-
derived data set confirmed that all 3 previously described Dnmt3b isoforms are 
expressed in rESCs and predicted an additional isoform lacking exon 22.  To 
verify the existence of the undescribed isoform, RT-PCR analysis with primers 
designed within exons 21 and 24 was performed followed by nucleotide 
sequence analysis of all resulting amplicons.  This analysis, in combination with 
RT-PCR performed with additional primer sets within other exons (data not 
shown) confirmed that all 4 isoforms identified by RNA-seq analysis were present 
in the rESCs (Figure 4.3).  Interestingly, the undescribed ESC isoform was not 
present in the control kidney sample and may represent an ESC-specific isoform. 
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Lef1 is involved in the Wnt signaling pathway which plays a role in determining 
cell lineage (Mao and Byers 2011).  Lef1 has a total of 11 exons and six isoforms 
have been described. The RNA-seq data predicted an additional isoform which 
skips exons 2, 3, and 6.  Primers were designed to enable amplification of the 
entire gene from exon 1 to exon 11 by RT-PCR analysis.  Based on RT-PCR and 
nucleotide sequence analysis of the resulting amplicons, three isoforms were 
detected: the full length isoform, one in which exon 6 was skipped, and one in 
which exons 2, 3, and 6 were skipped (Figure 4.3).  The other 4 known isoforms 
differ by only a few base pairs and could not be identified effectively using this 
assay.  However, the assay did confirm the presence of the undescribed isoform 
as intended. 
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Figure 4.3. Nras, Dnmt3b, Lef1 isoform confirmation.  The schematics on the left represent 
the coding region of each isoform. Blue boxes represent exons.  Exons are not drawn to scale. 
Arrows indicate location of primers (Appendix C).  Gel images to the right represent RT-PCR 
results. For each RT-PCR gel image: L = DNA Ladder (with size in base pairs indicated to the left 
of the image), rESC = rat embryonic stem cell sample, K = adult rat kidney control, and * stands 
for predicted undescribed isoform. (A) Nras, (B) Dnmt3b, (C) Lef1.  
Undescribed Poly (A)+ Transcripts 
 
Reads aligned to the rn5 reference genome, but lacking any known or predicted 
transcript according to RefSeq (/refseq/release/10/20/2012) were assigned 
undescribed poly (A)+  transcript status.  To verify the undescribed poly (A)+  
transcript have not been previously described, ENSEMBL, UCSC, and NCBI 
databases were consulted.  In total, 133 undescribed poly (A)+  transcripts were 
predicted.   
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To verify this prediction, 2 undescribed poly (A)+  transcripts (71 & 80) were 
predicted to have 2 exons each was chosen for RT-PCR verification.  Neither of 
these predicted transcripts had homology to any known transcript.  The 
nucleotide sequences of these predicted transcripts were used for a BLASTN 
analysis using the RefSeq database.  The closest match for 71 was a 79% 
identity match for the gene C1p2a-like from Apis flora.  The closest match for 80 
was a 85% identity to an uncharacterized rat gene LOC100911535.  Of note, 
LOC100911535 was not detected in the rESC samples.   
Based on this analysis, primers were designed to amplify each “exon” of each 
transcript.  Genomic DNA was chosen as a control to demonstrate the assay was 
possible.  However, the conditions are not optimized for genomic DNA for the 
putative full length transcript due to the difference in size.  Of the four exons 
tested, only exon 2 for predicted poly (A)+  80 was confirmed (Figure 4.4). 
It is unclear why there was lack of confirmation for the 4 “exons” chosen for 
confirmation.  A possible explanation could be the lack of sensitivity for the 
assay.   Taking into account the numbers of reads and gene length for 71 and 
80, only 2 and 14 full length transcripts were present in the data set, respectively. 
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Figure 4.4. Undescribed predicted poly (A)
+ transcript confirmation.  The diagram on the left 
represent the predicted undescribed poly A transcripts for 80 and 71.  Boxes represent exons.  
Arrows indicate location of primers (Appendix C).  For each RT-PCR gel image: L = DNA ladder 
(with size in base pairs indicated to the left of the image), cD = cDNA for rESC, G = genomic DNA 
for rESC (positive control), NRT = no reverse transcriptase (negative control). 
 
Rat, Human, and Mouse ESC Paired End RNA-seq Comparison 
 
The rESC data set was compared to publicly available paired end RNA-seq data 
sets for a human ESC line (GSM958733) and a mouse ESC line (GSM521650) 
(Birney et al. 2007; Guttman et al. 2010).  All post sequence analyses were 
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conducted in the same manner for all three data sets.  The number of genes 
detected for all three species in addition to the number of reads and the type of 
sequencer used are summarized in Table 4.1.   
In order to compare expression patterns among species, it was first necessary to 
insure that orthologs could be accurately identified. To compare the data sets, 
orthologs for all expressed genes for each species  were determined by using g-
profiler (Reimand et al. 2011).   Any gene that did not have an ortholog in all 
three species was removed: this resulted in 18% rat, 26% mouse, and 34% 
human genes removed from further analysis (Table 4.4). It is important to note 
that most, if not all, of these genes were eliminated due to deficiencies in 
annotation and not because they are unique to a given species (Table 4.5). The 
higher percentage of genes eliminated in the human and mouse data set is a 
reflection of the fact that the rat genome was sequenced later than both the 
mouse and human genomes and the annotation in the rat is not as robust.  Using 
the set of orthologous genes, the number of genes expressed in ESCs among all 
three species and among species was determined (Figure 4.5).  
Table 4.4. Summary of orthologs by species 
  Shares an ortholog 
Species Genes Detected Mouse Rat Human All Species 
hESC 17,874 11,739 11,739 - 11,739 
mESC 14,417 - 10,611 10,726 10,611 
rESC 10,931 9,370 - 9,465 8,968 
 
 
 45 
 
Table 4.5 Comparison of genomes and annotated transcripts in available 
databases 
 Rat (Rnor 5.0) Mouse (GRCm38.p1) Human (GrCH37.p10) 
Genome Size 2.7 Gbp 2.7 Gbp 3.2 Gbp 
# of Genes 29,100 36, 506  41,607 
Reference (Gibbs et al. 2004) (Gnerre et al. 2011) (Gnerre et al. 2011) 
 
 
Figure 4.5. Comparison of expressed genes in rat, mouse, and human ESCs. ESC’s gene 
comparison among species was done only with orthologous genes.  Total number of genes is 
11,739, 10,611, and 8,968 for human, mouse, and rat, respectively.   
Analysis was performed using Toppcluster to determined statistically significant 
pathways for all three species in order to draw comparisons (Figure 4.6) 
(Praneenararat et al. 2012).  In summary, mouse and rat share more common 
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pathways than any other species combination.  Sixty-nine pathways are rodent 
specific, 23 shared among all three species, 1 among human and mouse only, 
and 0 among rat and human only.  Additionally, 42 pathways are specific for rat, 
23 are specific for mouse, and 1 is specific for human. The top 10 statistically 
significant pathways as defined by a <0.05 p-value suggest that all three species 
have statistically significant expression of HIV pathways, NGF signaling, and 
Erbβ downstream signaling. Included in the 21 pathways shared by all three 
species are cancer pathways, Tgf- β, and Wnt signaling pathways.  
 
Figure 4.6 Toppcluster pathway analysis of rat, human, and mouse ESCs.   Pathways are 
represented by boxes. Sixty-nine pathways are shared exclusively among mouse and rat, 23 are 
shared among all three species, 1 is shared exclusively among human and mouse, and 0 are 
shared exclusively among rat and human.  Forty-two pathways were specific for rat, 23 are 
specific for mouse, and 1 is specific for human.   
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Oct4 (Pou5F1) is a transcription factor that plays an essential role in the self-
renewal capacity of ESCs.  An Oct4 centric protein network had been previously 
described for mouse ESC (Pardo et al. 2010; van den Berg et al. 2010).  Using 
the RNA-seq-derived data sets for rat, mouse and human, we examined the 
expression of the 169 genes that are part of the Oct4 network.  Of these 169 
genes, only 22 were not expressed in all three species (Figure 4.7).  Of these 22 
genes, 16 were expressed in mouse and human but not rat, 1 was expressed in 
rat and mouse but not human, 1 was expressed only in human, and 4 were 
expressed in rat and human but not mouse.  This later observation was 
unexpected as the network was based on expression data from mouse ESCs 
therefore all of the genes were expected to be represented in the mouse data set 
we used.  However, it is possible that differences among culture conditions, the 
fact that different cell lines were used in the different studies, or that the detection 
methods used to assess expression may account for the discrepancy.    
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Figure 4.7. Oct4 centric protein network. The network represents proteins that interact with 
Oct4 based on previous work using mESCs (Pardo et al. 2010; van den Berg et al. 2010).  Large 
circles represent protein complexes. White = genes expressed in all three species, Orange = 
genes expressed in mouse and rat, Teal = genes expressed only in rat, Yellow = genes 
expressed only in mouse, Red = genes expressed only in human. 
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CHAPTER V 
 
 
DISCUSSION 
 
In this study, we characterized the mRNA transcriptome of a Dark Agouti rat 
embryonic stem cell line in order to provide a publicly available normal reference 
for future experiments.  Towards this goal, we generated 50-mer paired end 
reads for 2 samples at a high sequence depth (247 million reads), mapped the 
sequences against the UCSC RGSC v5.0 database (March, 2012), and 
generated a list of expressed genes and their relative expression values as 
measured in RPKMs.   Because our results were highly repeatable based on the 
observation that only 32 genes had a >1 fold expression difference among the 
replicates and the correlation of expression was high (R2 = 0.99), we limited our 
data set to 2 replicates.  After strict filtering by removal of duplicate and low 
quality reads, and setting the criteria of inclusion to those genes with >1 RPKM 
expression, a total of 10,931 genes were used for further analysis.  We chose to 
use more stringent criteria in an effort to eliminate analysis artifacts.  
In order to validate the observation that 32 genes showed a >1 fold expression 
difference among biological replicates, primers for 4 genes were chosen.   Based 
on our results the predicted RNA-seq fold change among biological replicates 
appears to be accurate.  This correlates with previously reported findings that 
RNA-seq expression has a high correlation with quantitative RT-PCR results 
(Fang and Cui 2011). 
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The most highly expressed rESC genes correlated with pathways and GO terms 
associated with insulin metabolism, embryogenesis, and neural growth factor 
signaling.  Since insulin is a component of rESC media, finding upregulated 
genes for insulin metabolism was not surprising.  ESCs are isolated at the 
blastocyst stage, so upregulation of genes involved with embryonic development 
is also not unexpected.  However, it is interesting that neuronal growth factor 
signaling is upregulated in rESC as well as in human and mouse ESCs.  
Upregulation of NGF signaling is commonly used to induce embryonic stem cells 
to differentiate into neurons, therefore its role in the embryonic stem cell state is 
not clear (Wobus et al. 1988; Schuldiner et al. 2000; Bibel et al. 2004).   
Additional analysis was performed to detect undescribed isoforms. Alternative 
splicing is an important mechanism for enabling a single gene to code for 
multiple proteins and it results in functional diversity of these proteins in different 
tissues and cell types.  Given the unique nature of ESCs, the presence of 
undescribed isoforms that have not been previously reported in other tissues or 
cell types was not unexpected.  To validate our data sets using alternative 
methodology, three predicted undescribed isoforms were chosen for confirmation 
by RT-PCR and nucleotide sequence analysis. Primers were designed to allow 
amplification of key regions of predicted isoforms.  All predicted undescribed 
isoforms chosen for analysis were confirmed demonstrating that is possible to 
identify undescribed isoforms using RNA-Seq.  This does not however, explain 
what the biological explanation for the presence of these undescribed isoforms. 
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RNA-seq has the capability to detect undescribed poly (A)+ transcripts.  It is not 
surprising that there are undescribed predicted transcripts in rESCs as 1) 
annotation in rat is not as robust as human and mouse and 2) noncoding RNAs 
with poly (A)+  tails such as lincRNA were identified in mESCs (Guttman et al. 
2010).  Primers were designed to allow for RT-PCR amplification of the entire 
transcript and each “exon”.  Of the 4 exons tested, only 1 was confirmed.  The 
reason for this lack of confirmation is hypothesized as due to the sensitivity of the 
assay rather than an error in the RNA-seq analysis.  RNA-seq is capable of 
detecting a transcript down to one copy (Jiang et al. 2011).  It is predicted that 
only 2 and 14 full length transcripts are present for the predicted poly A+ 
transcript 71 and 80.  In order to verify the validity of these findings, further 
testing capable of detecting 1 copy of a transcript will be necessary.   
In order to potentially learn more about the commonalities and differences among 
ESCs from different species, the rat embryonic stem cell data set was compared 
to publicly available paired-end RNA-seq mouse and human ESC data (Birney et 
al. 2007; Guttman et al. 2010).  Despite being performed at different sequencing 
depths, all three data sets were paired end in order to provide a more accurate 
comparison.  The algorithms associated with aligning reads consider a single 
read length in order to gain specificity in alignment.  By using both ends of a read 
it allows for greater accuracy of an alignment by essentially extending the length 
of read.  If a dataset with single end reads were used in an analysis with paired 
end reads, the dataset with single end reads would have a less accurate 
alignment when compared with a paired end dataset.  Since each species was 
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performed at a different sequence depth, we did not make any comparisons 
related to relative expression levels among the three species. 
In our analysis, expressed genes that were shared in common among all three 
species can help establish common ESC expression profiles that may uniquely 
define ESCs.  Genes that were expressed only in one species or only among two 
species may reflect fundamental differences in the ESC transcriptomes of 
different species or alternatively, they may be artifacts of differences in culture 
conditions. Of note, all three species cell lines were cultured in different media, 
and the type of media influences expression of different signaling pathways 
(Kunath et al. 2007; Buehr et al. 2008; Li et al. 2008; Hirai et al. 2011).  Because 
of this, when genes are expressed only in one or two species, it is difficult to 
speculate about the significance of that finding. 
The analysis for pathway enrichment and GO terms was done using only the set 
of orthologous genes.  Many of these pathways are labeled according to the 
context in which they were discovered such as HIV infection and influenza.  
Genes that are involved in these particular pathways are involved in normal 
cellular functions.  It is not clear why these particular genes are upregulated in 
ESCs.  One possible explanation is that these genes are vital in order for these 
viruses to “rewire” the host cell in order to propagate.  This information provides a 
starting point for exploring the gene network and the biological role of this 
molecular pathway in ESCs.   
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Further analysis of a protein interaction network based on Oct4 expression in 
mESC revealed differences across all three species (Pardo et al. 2010; van den 
Berg et al. 2010).  Oct4 is fundamental in maintaining the pluripotency network 
for mESC, so exploring differences in all three species may assist in defining the 
ESC state (Niwa et al. 2000).  In total 22 genes were differentially expressed 
among the three species.  Possible explanations for these differences could be 
related to dissimilarity in ESC media or they could truly represent species-
specific gene expression.  A few genes such as the transcript 2810474O19Rik 
have no known function, but have been repeatedly identified as being expressed 
in mESCs (Ko et al. 2000; Diez-Roux et al. 2011).  A few genes such as Act16a 
which is involved in TNF-alpha signaling could be linked to media differences 
(Gotschel et al. 2008).  rESC media uses inhibition of GSK-3, which modulates 
TNF-alpha signaling.  Several genes are involved in epigenetic regulation such 
as Nr0b1 (Dex-1). Nr0b1 is of particular interest because it has been previously 
shown that removal or down regulation of this gene results in loss of pluripotency 
in mESC (Khalfallah et al. 2009).  All of these genes were not detected in rat, but 
were in mouse and human, so their role in maintaining the rESC state is unclear.   
ESCs for all three species have a high number of expressed genes assigned to 
cancer pathways.  It has been proposed that stem cells have the potential to give 
rise to cancer (Reya et al. 2001; Polyak and Hahn 2006; Dalerba et al. 2007; 
Friedmann-Morvinski et al. 2012) and the data would support this.  Consistent 
with previous reports implicating the Erbβ, TGF-β, and Wnt signaling pathways in 
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ESC pluripotency (Alvarez et al. 2012; Yeo and Ng 2013), these same pathways 
were statistically significant for the ESCs from all three species in our analysis.  
This data is only a snapshot at one time point of one strain of rESCs.  In order to 
provide a deeper examination of the normal transcriptome of rESCs, RNA-Seq 
would need to be performed on 1) multiple strains of rESCs and 2) multiple time 
points.   
Examining multiple strains of rESCs would help elucidate what the key 
components for rESC maintenance are.  From this dataset alone, it will be 
impossible to determine what gene expression patterns are unique to the Dark 
Agouti strain that these rESCs were isolated from.  Different rat strains have 
different phenotypes and presumably their rESCs would express different gene 
patterns.  By overlaying these gene patterns, it would be possible to reveal what 
the consistent rESC pattern.  From this pattern, a test could be provided for 
identification of future rESC lines.   
Exploring multiple time points would help answer a couple of questions 
concerning rESCs.  The longer ESCs are passaged it becomes more difficult to 
produce germline competent chimeras.  Examining multiple time points should 
help elucidate what critical change happens to causes this difficulty.  This would 
lead to 1) improvements in media conditions and 2) help provide the key to 
understanding how germline transmission from ESC occurs.  Another question 
concerning ESC biology is whether ESCs are a natural phenomenon or a product 
of in vitro conditions. By documenting what the changes are to ESCs as they 
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“age” would provide insight to the degree ESCs change from the environment 
they are isolated. 
Additional experiments to understand rESC biology are essential.  Examination 
on a global scale micro RNAs and the epigenome of rESC would provide insight 
to the regulation of rESC transcriptome.  Examining only mRNA does not provide 
a complete picture of rESC biology on a global scale.  It could be argued that the 
factors controlling mRNA expression are just as important as the expression 
levels of mRNA. 
In conclusion, we have presented the first transcriptome for rat ESCs using RNA-
seq analysis.  It is envisioned that this data set will be of use by serving as a 
control for future experiments.  To this end, the dataset for this paper have been 
made publicly available (See Methods). 
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Appendix A 
 
Mouse Embryonic Fibroblast (MEF) Media 
GMEM ((Sigma, St. Louis, MO G5154) 
10% FBS (HyClone SH30070.03) 
1% GlutaMAX™-I (2 mM) (Invitrogen, Grand Island, NY (Gibco) 35050-061) 
1% penicillin/streptomycin (Invitrogen, Grand Island, NY 15140-122) 
  
MEF Preparation:  For 250 mL MEF medium, add 25 mL FBS, 2.5 mL 
GlutaMAX™-I solution and 2.5 mL penicillin/streptomycin solution to 220 mL 
GMEM and filter. Store at 4 °C and use within one month. 
Rat Embryonic Stem Cell Media (2i) Stock Solution Preparation 
All stock reagents are made at least one day prior to making media and filtered 
sterilized individually using pore size of 0.2 µM (Fisher, Ashevile, NC (Thermo 
Scientific) 09-740-39A, SCGP00525, or (BD Falcon) 301603) and stored in 
amber Eppendorf tubes.  
Apo-Transferin (Sigma, St.Louis, MO, T1147) (100 mg/mL) stock solution: 
Dissolve 500 mg in 5 mL sterile water overnight at 4 °C.  Prepare in 1 mL 
aliquots and store at -20 °C for up to 1 year. 
 
BSA (Invitrogen, Grand Island, NY 15260-037) 7.5% solution stock solution: 
Prepare in 1 mL aliquots in 1.5 mL tubes and store at -20 °C for up to 1 year. 
 
Insulin (Sigma, St.Louis, MO, I1882) 25 mg/mL stock solution: Dissolve 100 mg 
insulin in 4 mL sterile 0.01 M HCl (Sigma, St.Louis, MO, H9892) overnight at 4 
°C. Prepare 100 μl aliquots in 0.5 mL tubes. Store at -20 °C for up to 1 year.  
 
Progesterone (Sigma, St.Louis, MO, P8783) 0.6 mg/mL stock solution: Dissolve 
6 mg in 10 mL high-grade ethanol. Prepare aliquots (volume is of your own 
preference) and store at -20 °C for up to 1 year.  
 
Putrescine (P5780) 160 mg/mL stock solution: Dissolve 1.6 g in 10 mL sterile 
water. Prepare 0.5 mL or 1 mL aliquots and store at -20 °C up to 1 year.  
 
Sodium selenite (Sigma, St.Louis, MO, S5261) 3 mM stock solution: Must be 
prepared in fume hood. Due to the air circulation in a fume hood, it is necessary 
to prepare 2 dilutions in order to obtain a 3 mM stock solution. First dissolve 25.9 
mg in 5 mL sterile water to make a 30 mM stock and then add 0.5 mL of this 
stock into 4.5 mL sterile water to obtain a 3 mM stock solution. Prepare 0.5 mL 
aliquots and store at -20 °C for up to 1 year. 
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CHIR99021 (Stemgent 04-0004) 3 µM stock solution: Dissolve 2 mg into 1.43 mL 
of Dimethyl sulfoxide (DMSO) (Sigma, St.Louis, MO, D248). Prepare aliquots in 
200 µL and store at -80 °C for up to 1 year. 
PD0325901 (Stemgent 04-0006) 0.5 µM stock solution: Dissolve 2 mg into 8.2 
mL of Dimethyl sulfoxide (DMSO) (Sigma, St.Louis, MO, D248). Prepare aliquots 
in 200 µL and store at -80 °C for up to 1 year. 
N2 stock solution 
1 ml apo-Transferrin  
0.67 mL BSA  
33 μl progesterone   
100 μl putrescine  
10 μl sodium selenite  
 
8.187 mL DMEM/F12  
 
Prepare 1 mL aliquots and store at -20 °C for up to 1 year. 
2i Media Preparation 
1. For 200 mL of media, thaw out 1 mL of N2 stock, 2 mL of B27 (Invitrogen, 
Grand Island, NY, 17504-044), 1 mL of Glutamax, 200 µL of CHIR99201, 
200 µL of PD0325901, and 100 µL of insulin. 
2. In one 500 mL beaker add 100 mL of DMEM/F12 and 1 mL N2 stock. 
3. In another 500 mL beaker add 100 mL Neurobasal media, 2 mL B27, and 
1 mL Glutamax. 
4. Mix both beakers by pouring into one another. 
5. Immediately rinse out the empty beaker 10x with Milli-Q water to avoid 
residue from forming on glass. 
6. While stirring media with 5 mL serological pipet tip add drop by drop, 100 
µL of insulin to avoid precipitation of the insulin. 
7. Add 200 µL of CHIR99201, 200 µL of PD0325901 and 2 mL of β-
mercaptoethanol (Millipore, Billerica, MA ES-007-E). 
8. Mix well and pour into 250 mL filter unit and filter. 
9. Immediately rinse out the empty beaker 10x with Milli-Q water to avoid 
residue from forming on glass. 
10. Aliquot media at 40 mLs. 
11. Store at 4 °C and use within a month. 
Cryopreservation of rat ESCs 
1. rESCs were passaged for >3 passages as previously described in the 
Materials and Methods section. 
2. On the day to cryopreserve the cells, prepare cryovials and media prior to 
preparing cells.   
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3. Cryopreservation media is 90% 2i media and 10% DMSO.  Prepare media 
on ice by slowly dropping DMSO in the 2i media as the reaction is 
exothermic and keep on ice. 
4. To prepare the cells, obtain single cell suspension as described in the 
Materials and Methods section and count using a hemocytometer. 
5. Cells are pelleted at 150 g for 5 min. 
6. While in the hood on ice, pipette off the 2i media and resuspend the cells 
in cryopreservation media to a density of 1x10^6 cells/mL.  Aliquot 1 mL of 
cells per cryotube and place the vials into a NALGEN Cryo 1 °C freezing 
container (Thermo Scientific 5100-0001). 
7. Place the container into a -80 °C overnight and transfer the vials to liquid 
nitrogen the following day for long term storage. 
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Appendix B 
 
 
F 1- Scatter plot of gene expression. Demonstrates the high correlation of gene 
expression among rESC samples 1 & 2. R2 = 0.9919. 
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Appendix C 
 
Name 5’ -Sequence -3’ 
Rat Dnmt3b Ex 21 F CGCCATCAAGGTTTCTGCTG 
Rat Dnmt3b Ex 24 R CCCCACACAGGTGAGCTAAG 
Rat Lef1 Ex 1 F-2 CGAGATCAGTCACCCCGAAG 
Rat Lef1 Ex 11 R TGTAGGCAGCTGTCATTCTGGG 
Rat Nras Ex 5 F GGGTGTGGAGGATGCCTTTT 
Rat Nras Ex 7 R AGCCGAGTGAGGAGGTAGTT 
NewGene 80 Ex1F ACCAGGGAATGCCTGCTACTA 
NewGene 80 Ex1R TTTGCCCAACTCATCCCACT 
NewGene80  Ex2F CCACCCAGATCTGAAGGGAC 
NewGene80  Ex2R CCAGATGGTGCTAGGCGTTT 
NewGene71 Ex 1F TGAGCATTCTTTGGTTGCTGT 
NewGene71 Ex 1 R CGAGCCAGAATCTGCAGTCA 
NewGene71 Ex2 F CCTTGGCTATGGGCAACTGA 
NewGene 71 Ex2 R CTGCCATGGAGACCCAGTTT 
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